drugset / Trial / NCT04414020

Cytoprotective Effect and Clinical Outcome of Perioperative Proesterone in Brain Tumors

NCT04414020

Phase 1 Unknown 26 enrolled Minia University
RandomizedParallel-groupDouble-blindTreatment

Summary

Neuronal injury is evident in elective craniotomy for space occupying lesions. Surgical trauma and mechanichal impact of the tumor causes neuronal injury. Neurosreroid progesterone is a neurotransmittern , trail to use in abolishing neurotoxcicty

Timeline

Start
2020-06-01
Primary completion
2020-08-31
Completion
2020-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 1 mg Intramuscular

Indications